299 results on '"Laronga, C."'
Search Results
2. Differences in Gene Expression between Black and White Patients with Triple Negative Breast Cancer Is Not Implicated in Locoregional Recurrence Risk
3. PV-0048 The Radiosensitivity Index (RSI) predicts for outcomes in triple negative breast cancer
4. Abstract OT2-04-05: Phase II trial of pre-operative stereotactic ablative radiotherapy (SABR) in early-stage breast cancer
5. OC-0158: Histologic heterogeneity of triple negative breast cancer: a National Cancer Center Database study
6. A blood test to discriminate sentinel lymph node (SLN) positive breast cancer using SELDI-TOF (Surface-enhanced laser desorption/ionization-time of flight) mass spectrometry
7. Proteomic analysis of BRCA-1 breast cancer, BRCA-1 carriers and sporadic breast cancer
8. Characteristics of Radiation Therapy for Medullary Carcinoma of the Breast in the National Cancer Database
9. Rates of Whole Breast Radiation Therapy Following Intraoperative Radiation Therapy Using 2009 and 2016 ASTRO Consensus Guidelines
10. A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
11. Variability in Guidelines Effects Rates of Whole-Breast Radiation Therapy Following Intraoperative Radiation Therapy
12. Breast-conserving surgery in patients with Paget's disease
13. Intraoperative radiotherapy for early breast cancer and age: Clinical characteristics and outcomes
14. Prolonged impact of chemotherapy on fatigue in breast cancer survivors: a longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls
15. Changes in Patient Weight After the Diagnosis and Treatment of Breast Cancer
16. Abstract P1-01-13: Patterns of definitive axillary management in the era prior to reporting ACOSOG Z0011: comparison between NCCN Centers and hospitals in Michigan
17. Abstract P4-14-09: Feasibility of liposuction for treatment of arm lymphedema from breast cancer.
18. Abstract P4-17-01: The effect of body mass index on breast reconstruction outcomes.
19. Ipsilateral Locoregional Recurrence After Axillary Lymph Node Dissection in Patients with Breast Cancer
20. Radiologic Evaluation of Palpable Nodules Following Autologous Fat Grafting in Breast Reconstruction
21. Oncotype DX in Patients Treated with Targeted Intraoperative Radiotherapy
22. P5-11-14: Flat Epithelial Atypia of the Breast: A Single Institution Experience.
23. P4-09-28: Comparison of Oncotype DX (ODX) and Mammostrat (MS) Risk Estimations and Correlations with Histologic Tumor Features in Low Grade, ER-Positive Invasive Breast Carcinoma (BC).
24. Results of Oncotype DX in early-stage invasive lobular carcinoma.
25. Pathologic characteristics of second breast cancers (SBC) among women previously treated for ductal carcinoma in situ (DCIS) with breast conservation.
26. Abstract P6-01-03: Invasive Micropapillary Carcinoma (IMPC) of the Breast: An Uncommon but Aggressive Special Type of Breast Cancer
27. Gene expression profile testing for breast cancer: Patterns and predictors of use and impact on chemotherapy.
28. Attaining Negative Margins in Breast-Conservation Operations: Is There a Consensus among Breast Surgeons?
29. The Effect of Oncotype Dx® Recurrence Score on Treatment Recommendations for Patients with Early Stage Estrogen Receptor Positive Breast Cancer.
30. Margin Assessment in Breast Conservation for Ductal Carcinoma In Situ.
31. Estimation of Risk of Recurrence of Early Stage Estrogen Receptor Positive Breast Carcinoma by Surgical and Medical Oncologists and Pathologists Compared to the Oncotype Dx® Recurrence Score.
32. Medical Oncology Breast Cancer Quality Indicators: Adherence by the Florida Initiative for Quality Cancer Care (FIQCC) Consortium.
33. Neoadjuvant Intratumoral Injection of Dendritic Cells in Breast Cancer.
34. Surgical/Pathologic Breast Cancer Indicators: Adherence by the Florida Initiative for Quality Cancer Care (FIQCC) Consortium.
35. P42 The effect of Oncotype DX® Recurrence Score on treatment recommendations for geriatric patients with early stage hormone receptor positive breast cancer
36. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer
37. Minimal access breast surgery – A single breast incision for breast conservation surgery and sentinel lymph node biopsy
38. Male breast cancer: follow-up recommendations after surgery.
39. Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision?
40. Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy
41. Microinvasive Breast Cancer and the Role of Sentinel Node Biopsy: An Institutional Experience and Review of the Literature
42. Psychologic Intervention Improves Survival for Breast Cancer Patients: A Randomized Clinical Trial
43. Total Skin-Sparing Mastectomy: Complications and Local Recurrence Rates in 2 Cohorts of Patients
44. Occult Breast Lesion Localization plus Sentinel Node Biopsy (SNOLL): Experience with 959 Patients at the European Institute of Oncology
45. Multifocal Breast Cancer in Women ≤35 Years Old
46. Population-based Case-Control Study of Diabetes and Breast Cancer Risk in Hispanic and Non-Hispanic White Women Living in US Southwestern States
47. 4–26 Predictors of Residual Invasive Disease after Core Needle Biopsy Diagnosis of Ductal Carcinoma In Situ
48. Influence of Frozen-Section Analysis of Sentinel Lymph Node and Lumpectomy Margin Status on Reoperation Rates in Patients Undergoing Breast-Conservation Therapy
49. 4–31 Feasibility and Accuracy of Sentinel Lymph Node Biopsy After Preoperative Chemotherapy in Breast Cancer Patients With Documented Axillary Metastases
50. 3–44 Upstaging and Improved Survival of Early Breast Cancer Patients after Implementation of Sentinel Node Biopsy for Axillary Staging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.